19:58:07 EDT Fri 18 Jul 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

T:MDP - MEDEXUS PHARMACEUTICALS INC. J - https://www.medexus.ca/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MDP - T  0.52.81·2.851.42.81-0.07-2.430.382672.88  2.90  2.815.56  1.7115:59:59Jun 2515 min RT 2¢
TSX - T0.52.81·2.851.42.81-0.07-2.426.171432.88  2.90  2.815.56  1.7115:59:5915 min
Alpha - A 2.83-0.05-1.71.3412.83  2.83  2.8314:55:0215 min
Omega - O 2.85-0.03-1.00.2112.85  2.85  2.8510:56:3715 min
Pure - P 2.82-0.06-2.10.9262.90  2.90  2.8214:36:2315 min
Chi-X - X 2.86-0.02-0.70.7222.87  2.87  2.8610:56:3715 min
CX2 - H 2.85-0.03-1.00.2112.85  2.85  2.8510:56:3715 min
CXD - D 2.880.106    Jul 1715 min
TriAct - M 2.880.0905    Sep 11/2015 min
Lynx - Y 2.87-0.01-0.30.6222.88  2.88  2.8710:56:3715 min

Recent Trades - Last 10 of 67
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:59T2.81-0.073007 TD Sec79 CIBCK
15:59:59T2.82-0.064007 TD Sec79 CIBCK
15:53:27M2.83-0.05107 TD Sec7 TD SecE
15:34:43D2.81-0.073080 National Bank80 National BankE
15:34:43T2.81-0.074007 TD Sec80 National BankK
15:34:43T2.81-0.078,1007 TD Sec1 AnonymousK
15:34:06T2.82-0.065080 National Bank14 Virtu ITG
15:32:27T2.82-0.0610080 National Bank39 Merrill LynchK
15:27:55T2.81-0.076007 TD Sec1 AnonymousK
15:27:55T2.81-0.071007 TD Sec1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-06-25 18:40C:MDP3.35SEDAR Annual Information FormSEDAR Annual Information Form
2025-06-25 18:40C:MDP3.35SEDAR MD & ASEDAR MD & A
2025-06-25 18:29C:MDP3.35SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-06-25 18:16C:MDP3.35News ReleaseMedexus Announces Strong Fiscal Year 2025 Results, Including Initial Results from Launch of GRAFAPEX (treosulfan) for Injection in the United States
2025-06-17 20:20C:MDP3.03News ReleaseMedexus to file fiscal 2025 results June 25
2025-04-17 16:34C:MDP2.55News ReleaseMedexus completes listing agreement for Trecondyv
2025-04-07 16:19C:MDP2.17News ReleaseMedexus talks up market response to Grafapex
2025-03-14 14:15C:MDP2.57News ReleaseMedexus completes cancellation of Gleolan U.S. licence
2025-02-24 16:32C:MDP2.98News ReleaseMedexus's Grafapex for injection available in U.S.
2025-02-07 05:42C:MDP3.21In the NewsGlobe says Medexus Pharmaceuticals lowered to "hold"
2025-02-06 10:51C:MDP3.79News ReleaseCanadian Investment Regulatory Organization Trade Resumption - MDP
2025-02-06 10:45C:MDP3.79News ReleaseCanadian Investment Regulatory Organization Trading Halt - MDP
2025-02-06 10:35C:MDP3.79Resume TradingMedexus Pharmaceuticals to resume at 7:36 a.m. PT
2025-02-06 10:34C:MDP3.79Halt TradingMedexus Pharmaceuticals halted at 7:31 a.m. PT
2025-02-05 17:39C:MDP3.79SEDAR Interim MD & ASEDAR Interim MD & A
2025-02-05 17:38C:MDP3.79SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-02-05 17:31C:MDP3.79News ReleaseMedexus Announces Strong Fiscal Q3 2025 Results, Well-Positioned to Launch GRAFAPEX (treosulfan) for Injection in the United States
2025-02-04 17:54C:MDP3.87News ReleaseMedexus completes listing agreements with Ontario
2025-01-31 18:21C:MDP3.85News ReleaseMedexus to release fiscal Q3 results Feb. 5
2025-01-31 16:44C:MDP3.85News ReleaseMedexus Pharmaceuticals closes $30-million offering